Sb-705498 Rectal Pain Study

Summary

SB-705498 has demonstrated efficacy in several preclinical and human experimental pain models. This study will investigate the efficacy of SB-705498 in patients with rectal pain. This will be a double-blind, placebo-controlled, two-way crossover study. 21 patients with faecal urgency (Group 1), and 21 patients with IBS (Group 2) will complete this study.

Timeline

Start

2007-01-26

Primary completion

2007-09-01

Completion

2007-09-01

Drugs

Indications